In accordance with the decree of 19 May 2006, our investigator’s brochures summarize concisely, simply, objectively and impartially all the clinical and nonclinical data relating to the trial drug, as well as the assay of the investigational medicinal product, the dosage, the method of administration, and the safety monitoring procedures.